| Condition | Key Finding | Association | Board Exam Tip |
| Small Cell Lung Cancer (SCLC) | Hyponatremia, Hypercalcemia | SIADH (ADH), PT HrP | If hypercalcemic and not suppressed by high-dose dexamethasone, suspect PT HrP. |
| Lambert-Eaton Myasthenic Syndrome (LEMS) | Proximal muscle weakness; improves with use | SCLC antibodies against P/Q channels | The improvement with activity is the key differentiator from myasthenia gravis. |
| Immune Thrombocytopenic Purpura (ITP) | Thrombocytopenia, normal platelet function tests | Autoantibodies against GP2b3a | Treatment sequence: Corticosteroids -> IVIG -> Rituximab (SIRS). |
| Multiple Endocrine Neoplasia Type 1 (MEN1) | Parathyroid hyperplasia/adenoma; Pituitary adenoma; Pancreatic neuroendocrine tumor | "3 P's" or "3 H's" (Parathyroid, Pituitary, Pancreas) | Remember the specific tumors: VI Poma, Gastrinoma, Glucagonoma. |
| Topic | Key Point | Context | Exam Relevance |
| Hypercalcemia | PT HrP is the most common cause in malignancy (SCLC). | Causes "stones, bones, groans, and psychic overtones." | Use loop diuretics or Calcium Gluconate/Cinacalcet. Monitor for QT prolongation risk. |
| Hypocalcemia | Rescue agent: Calcium Gluconate. | Hypoparathyroidism (parathyroidectomy), Rhabdomyolysis, George syndrome. | Always suspect hypocalcemia after parathyroid gland manipulation. |
| Coagulopathy | vWD causes elevated PTT and prolonged bleeding time. | Deficiency of VWF affects both primary hemostasis (platelet plug) and secondary hemostasis (Factor VIII protection). | Differentiate from Glanzmann's (primary only) or Bernard-Soulier (primary only). |
| HOHF | Loss of capillary resistance/slowdown mechanism. | Occurs after creating an arteriovenous fistula for dialysis access. | High output failure is a classic complication of chronic hemodialysis patients. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| Long-term smoker presenting with polyuria, volume depletion, vomiting, and abdominal pain. | Squamous Cell Lung Cancer (SCC) or SCLC | SCC can produce PT HrP leading to hypercalcemia; the symptoms mimic nephrolithiasis/nephrogenic diabetes insipidus. |
| Proximal muscle weakness that improves after repetitive nerve stimulation. | Lambert-Eaton Myasthenic Syndrome (LEMS) | This pattern of improvement with use is pathognomonic for LEMS, often associated with SCLC antibodies against P/Q channels. |
| Patient presenting with a sensory level below the T4 dermatome following prostate cancer diagnosis. | Spinal cord compression from metastatic disease | Sensory levels are highly suggestive of spinal cord involvement; prostate cancer commonly metastasizes via Batson's plexus (vertebral venous plexus). |
| Severe bleeding, thrombocytopenia (<10k), and history of lupus/idiopathic cause. | Immune Thrombocytopenic Purpura (ITP) | Pathophysiology involves autoantibodies against platelet glycoproteins (GP2b3a); treatment follows the SIRS mnemonic (Steroids, IVIG, Rituximab). |
| Patient with a bulge in the inguinal canal and history of female reproductive issues. | Femoral Hernia | The femoral ring is more susceptible to incarceration/strangulation than the inguinal ring, especially in females. |
| Key Features | Distinguishing Findings | Next Step |
| Hypoparathyroidism (Post-parathyroidectomy) | Low PTH; low calcium; often acute onset. | Calcium Gluconate IV for symptomatic relief. |
| Rhabdomyolysis | High CK/myoglobin; muscle pain; hypocalcemia due to sequestration. | Aggressive hydration and monitoring of renal function. |
| George Syndrome | Congenital, T-cell deficiency (due to thymic agenesis); Hypoparathyroidism + Hypocalcemia. | Supportive care; immune replacement therapy for infections. |
| Key Features | Distinguishing Findings | Next Step |
| Acute Pancreatitis | Severe epigastric pain, elevated lipase/amylase. | NPO, IV fluids (crystalloids), Opioids; monitor for hypocalcemia. |
| Esophageal Rupture (Boerhaave) | Sudden onset severe chest/abdominal pain, vomiting, subcutaneous emphysema. | Immediate supportive care; diagnosis via water-soluble contrast endoscopy (e.g., Gastrografin). |
| High Output Heart Failure | Dyspnea, fatigue, edema in a patient on dialysis. | Identify the underlying cause (AV fistula, peritonitis) and manage fluid/volume status. |
🚨MEN1 Triad: Always remember the three systems: Parathyroid (hypo Ca), Pituitary (prolactinoma), and Pancreas (VI Poma, Gastrinoma, Glucagonoma).
| Condition | Association | Mechanism | Clinical Significance |
| Small Cell Lung Cancer | Lambert-Eaton Myasthenic Syndrome (LEMS) | Antibodies against P/Q type calcium channels at the neuromuscular junction. | LEMS is a highly specific paraneoplastic syndrome; improvement with use is key. |
| Multiple Endocrine Neoplasia Type 1 (MEN1) | VI Poma, Gastrinoma, Glucagonoma | Pancreatic neuroendocrine tumors arising from germ cell lineage. | The "3 P's" triad must be screened for in any patient presenting with these symptoms. |
| Acute Pancreatitis | Hypocalcemia | Saponification reaction (calcium binding to fatty acids). | Always check calcium levels and treat hypocalcemia aggressively, especially if ECG changes are present. |
| High Output Heart Failure | Arteriovenous Fistula Creation | Bypassing the capillary bed's resistance/slowdown mechanism. | A classic complication of chronic dialysis patients; requires careful monitoring of cardiac status. |
| Term | Definition | Context | Example |
| PT HrP | Parathyroid hormone-related protein. | Hypercalcemia due to malignancy (e.g., SCLC). | Causes hypercalcemia by mimicking PTH action on bone/kidney, leading to "stones, bones, groans." |
| SIADH | Syndrome of inappropriate ADH secretion. | Hyponatremia; often associated with small cell lung cancer. | Leads to water retention and dilutional hyponatremia. |
| WOH/A Syndrome | Watery diarrhea, hypokalemia, achlorhydria. | Caused by VI Poma (Vasoactive Intestinal Peptide). | The classic triad of a gut hormone excess tumor; leads to severe metabolic alkalosis. |
| Calcium Gluconate | Calcium salt used for IV administration. | Rescue agent for symptomatic hypocalcemia. | Used when calcium levels are low and the patient has ECG changes (prolonged QT interval). |
| Topic | Study Approach | Priority | Resources |
| Paraneoplastic Syndromes | Create flowcharts linking cancer type -> hormone/peptide -> resulting syndrome. | High | Review SCLC and SCC associations; memorize the "3 P's" of MEN1. |
| Coagulation Disorders | Use a differential table approach: What is defective (platelet vs factor)? Where does it act (primary vs secondary hemostasis)? | Medium-High | Focus on vWD, Glanzmann's, and Bernard-Soulier; remember the PTT/Bleeding Time pattern. |
| Surgical Emergencies | Visualize the pathology: What is the immediate life threat? What diagnostic tool must be avoided? | High | Boerhaave syndrome (no barium); Acute pancreatitis (NPO/fluids). |
🚫Mistake 1: Assuming all criteria for exudative effusion are required. Light's criteria only requires one of the three ratios (Pleural Protein/Serum Protein > 0.5, Pleural LDH/Serum LDH > 0.6, or Pleural LDH > 2/3 ULN) to be positive to classify an effusion as exudative.
🚫Mistake 2: Confusing primary vs secondary adrenal insufficiency. Primary AI (e.g., autoimmune destruction) causes low aldosterone and high renin; Secondary AI (e.g., chronic steroid use) preserves aldosterone because the RAAS axis is intact.